Market by Product (Consumables, Instruments, Imagers) Application (Biomedical & Biochemical Research, Disease Diagnostics, Agriculture, Other Applications) End-user (Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Centers, Other End-users) and Country Outlook | Forecast 2024-2032
According to Triton’s analysis, the Europe western blotting market is projected to rise at a CAGR of 4.06% in revenue over the forecast years 2024-2032.
Report scope can be customized per your requirements - Request Free Sample Report
The demand for the western blotting market in the European region is expected to grow due to the widespread awareness programs in many low- and middle-income countries that educate people on the fundamentals of HIV. These initiatives, along with funding from global organizations for free testing and treatment options, will create significant opportunities for manufacturers of western blotting products. Additionally, multilateral organizations, including UNITAID, the Global Fund, and other United Nations agencies, have been actively providing financial support for HIV-related efforts across the region.
The countries explored in this region include:
The United Kingdom secures a major market share with revenue of approximately $48.23 million in 2023.
As per the UK parliament, approximately 107,000 people in the UK are estimated to be living with HIV, which increases the demand for confirmatory testing using western blotting, which is essential after initial HIV screenings.
Ongoing monitoring of HIV patients requires western blotting to detect viral proteins and antibodies, boosting the use of western blotting consumables.
Research into HIV treatments and diagnostics in the UK further drives the demand for western blotting in laboratories and research centers.
Government funding and support for HIV research and personalized medicine initiatives also promote the growth of the western blotting market.
Western Blotting Market Forecast for Germany
Germany, classified as a Pattern I country by the WHO, witnesses most new HIV infections among high-risk populations. However, trends are shifting, with an increasing proportion of women—now accounting for 20% of new infections—being reported as newly infected. Additionally, the country’s policy of granting immediate access to new treatments following global approvals has created a healthcare system rich in treatment options but lacking in comprehensive professional guidance on treatment strategies and safety. As new cases rise and the diversity of patients expands, there is a need for ongoing monitoring and evaluation of the efficacy of new treatment strategies, resulting in the increased demand for western blotting methods.
The western blotting market is segmented based on product, end-user, and application. The product segment comprises consumables and instruments. The consumables include essential products required for the process, such as reagents, buffers, etc. Reagents and buffers are used for sample preparation, protein transfer, and detection, while primary and secondary antibodies play a key role in identifying target proteins.
Contender Analysis in the Western Blotting Market:
Bio-Techne Corporation, formerly known as TECHNE Corporation develops, manufactures, and sells biotechnology products and clinical diagnostic controls. The company offers specialized proteins such as cytokines and growth factors, along with immunoassays, small molecules, and other reagents for the research, diagnostics, and clinical control markets. The company operates across the US, Europe, and Asia, with its headquarters in Minneapolis, Minnesota.
In July 2024, Bio-Techne introduced a next-generation Simple Western system that surpasses the current Jess and Abby models in throughput, flexibility, and efficiency. This advanced instrument can process up to 100 samples simultaneously in just 3 hours, significantly increasing the number of samples scientists can analyze in a single day.
Other contenders in the studied market are Lumigen Inc, Rockland Immunochemicals Inc, Enzo Biochem Inc, Geno Technology Inc, Stressmarq Biosciences Inc, etc.
KEY DELIVERABLES OF THE REPORT:
Market CAGR during the forecasting years 2024-2032
Detailed data highlighting key insights, industry components, and market strategies
Comprehensive information and estimation of the western blotting market revenue growth in Europe and its influence on the parent market
In-depth study of forthcoming trends in consumer behavioral patterns
A meticulous analysis of the competitive landscape and Porter’s Five Forces
A wide-ranging study of factors that will challenge the Europe western blotting market’s growth during the upcoming years
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
WESTERN BLOTTING MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE WESTERN BLOTTING MARKET
2.1.1. COVID-19
IMPACT ON THE WESTERN BLOTTING MARKET
2.2. PORTER’S
FIVE FORCES ANALYSIS
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. KEY
MARKET STRATEGIES
2.3.1. PRODUCT
LAUNCHES
2.3.2. ACQUISITIONS
2.3.3. BUSINESS
EXPANSIONS
2.4. MARKET
DRIVERS
2.4.1. HIGH
DEMAND FOR PROTEOMICS
2.4.2. RISE
IN APPLICATIONS FOR WESTERN BLOTTING
2.4.3. GROWING
OCCURRENCE OF HIV AND LYME DISEASE
2.5. MARKET
CHALLENGES
2.5.1. ADVANCEMENTS
IN SUBSTITUTE TECHNOLOGIES
2.5.2. ELEVATED
ANTIBODY COSTS
2.5.3. REQUIREMENT
FOR IMPROVED PROCEDURAL EFFICIENCY TO ACHIEVE PRECISION
2.6. MARKET
OPPORTUNITIES
2.6.1. RISING
INTEREST IN TAILORED MEDICINE
2.6.2. WESTERN
BLOT INSTRUMENT AUTOMATION
2.6.3. PROGRESS
IN TECHNOLOGICAL ADVANCEMENTS
2.7. ANALYST
PERSPECTIVE
3. EUROPE
WESTERN BLOTTING MARKET – BY PRODUCT
3.1. CONSUMABLES
3.1.1. REAGENTS
AND BUFFERS
3.1.2. KITS
3.1.3. OTHER
CONSUMABLES
3.2. INSTRUMENTS
3.2.1. GEL
ELECTROPHORESIS INSTRUMENTS
3.2.2. BLOTTING
SYSTEMS
3.2.2.1. DRY
BLOTTING SYSTEMS
3.2.2.2. SEMI-DRY
BLOTTING SYSTEMS
3.2.2.3. WET
BLOTTING SYSTEMS
3.2.3. IMAGERS
3.2.3.1. CHEMILUMINESCENT
IMAGERS
3.2.3.2. FLUORESCENT
IMAGERS
3.2.3.3. OTHER
IMAGERS
4. EUROPE
WESTERN BLOTTING MARKET – BY APPLICATION
4.1. BIOMEDICAL
& BIOCHEMICAL RESEARCH
4.2. DISEASE
DIAGNOSTICS
4.3. AGRICULTURE
4.4. OTHER
APPLICATIONS
5. EUROPE
WESTERN BLOTTING MARKET – BY END-USER
5.1. RESEARCH
INSTITUTES
5.2. PHARMACEUTICAL
& BIOTECHNOLOGY COMPANIES
5.3. DIAGNOSTIC
CENTERS
5.4. OTHER
END-USERS
6. EUROPE
WESTERN BLOTTING MARKET – BY COUNTRY OUTLOOK
6.1. EUROPE
6.1.1. COUNTRY
ANALYSIS
6.1.1.1. UNITED
KINGDOM
6.1.1.1.1. UNITED
KINGDOM WESTERN BLOTTING MARKET FORECAST & PROSPECTS
6.1.1.2. GERMANY
6.1.1.2.1. GERMANY
WESTERN BLOTTING MARKET FORECAST & PROSPECTS
6.1.1.3. FRANCE
6.1.1.3.1. FRANCE
WESTERN BLOTTING MARKET FORECAST & PROSPECTS
6.1.1.4. SPAIN
6.1.1.4.1. SPAIN WESTERN
BLOTTING MARKET FORECAST & PROSPECTS
6.1.1.5. ITALY
6.1.1.5.1. ITALY WESTERN
BLOTTING MARKET FORECAST & PROSPECTS
6.1.1.6. REST
OF EUROPE
6.1.1.6.1. REST
OF EUROPE WESTERN BLOTTING MARKET FORECAST & PROSPECTS
7. COMPETITIVE
LANDSCAPE
7.1. MERCK
KGAA
7.1.1. OVERVIEW
7.1.2. PORTFOLIO
7.1.3. KEY
STRENGTHS
7.1.4. KEY
CHALLENGES
7.2. THERMO
FISHER SCIENTIFIC
7.2.1. OVERVIEW
7.2.2. PORTFOLIO
7.2.3. KEY
STRENGTHS
7.2.4. KEY
CHALLENGES
7.3. BIO-RAD
TECHNOLOGIES
7.3.1. OVERVIEW
7.3.2. PORTFOLIO
7.3.3. KEY
STRENGTHS
7.3.4. KEY
CHALLENGES
7.4. BIO-TECHNE
CORPORATION
7.4.1. OVERVIEW
7.4.2. PORTFOLIO
7.4.3. KEY
STRENGTHS
7.4.4. KEY
CHALLENGES
7.5. CELL SIGNALING
TECHNOLOGY INC
7.5.1. OVERVIEW
7.5.2. PORTFOLIO
7.5.3. KEY
STRENGTHS
7.5.4. KEY
CHALLENGES
7.6. LI-COR
INC
7.6.1. OVERVIEW
7.6.2. PORTFOLIO
7.6.3. KEY
STRENGTHS
7.6.4. KEY
CHALLENGES
7.7. ADVANSTA
INC
7.7.1. OVERVIEW
7.7.2. PORTFOLIO
7.7.3. KEY
STRENGTHS
7.7.4. KEY
CHALLENGES
7.8. AZURE
BIOSYSTEMS INC
7.8.1. OVERVIEW
7.8.2. PORTFOLIO
7.8.3. KEY STRENGTHS
7.8.4. KEY
CHALLENGES
7.9. PERKINELEMER
INC
7.9.1. OVERVIEW
7.9.2. PORTFOLIO
7.9.3. KEY
STRENGTHS
7.9.4. KEY
CHALLENGES
7.10. LUMIGEN
INC
7.10.1. OVERVIEW
7.10.2. PORTFOLIO
7.10.3. KEY
STRENGTHS
7.10.4. KEY
CHALLENGES
7.11. ROCKLAND
IMMUNOCHEMICALS INC
7.11.1. OVERVIEW
7.11.2. PORTFOLIO
7.11.3. KEY
STRENGTHS
7.11.4. KEY
CHALLENGES
7.12. ENZO BIOCHEM
INC
7.12.1. COMPANY
OVERVIEW
7.12.2. PORTFOLIO
7.12.3. KEY
STRENGTHS
7.12.4. KEY
CHALLENGES
7.13. GENO
TECHNOLOGY INC
7.13.1. COMPANY
OVERVIEW
7.13.2. PORTFOLIO
7.13.3. KEY
STRENGTHS
7.13.4. KEY
CHALLENGES
7.14. STRESSMARQ
BIOSCIENCES INC
7.14.1. COMPANY
OVERVIEW
7.14.2. PORTFOLIO
7.14.3. KEY
STRENGTHS
7.14.4. KEY
CHALLENGES
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: EUROPE WESTERN
BLOTTING MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 2: LIST OF PRODUCT
LAUNCHES
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF BUSINESS
EXPANSIONS
TABLE 5: EUROPE WESTERN
BLOTTING MARKET, BY PRODUCT, 2024-2032 (IN $ MILLION)
TABLE 6: EUROPE WESTERN
BLOTTING MARKET, BY CONSUMABLES, 2024-2032 (IN $ MILLION)
TABLE 7: EUROPE WESTERN
BLOTTING MARKET, BY INSTRUMENTS, 2024-2032 (IN $ MILLION)
TABLE 8: EUROPE WESTERN
BLOTTING MARKET, BY BLOTTING SYSTEMS, 2024-2032 (IN $ MILLION)
TABLE 9: EUROPE WESTERN
BLOTTING MARKET, BY IMAGERS, 2024-2032 (IN $ MILLION)
TABLE 10: EUROPE WESTERN
BLOTTING MARKET, BY APPLICATION, 2024-2032 (IN $ MILLION)
TABLE 11: EUROPE WESTERN
BLOTTING MARKET, BY END-USER, 2024-2032 (IN $ MILLION)
TABLE 12: EUROPE WESTERN
BLOTTING MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCES
ANALYSIS
FIGURE 2: EUROPE WESTERN
BLOTTING MARKET, BY PRODUCT, 2023 & 2032 (IN %)
FIGURE 3: EUROPE WESTERN
BLOTTING MARKET, BY CONSUMABLES, 2024-2032 (IN $ MILLION)
FIGURE 4: EUROPE WESTERN
BLOTTING MARKET, BY CONSUMABLES, 2023 & 2032 (IN %)
FIGURE 5: EUROPE WESTERN
BLOTTING MARKET, BY REAGENTS AND BUFFERS, 2024-2032 (IN $ MILLION)
FIGURE 6: EUROPE WESTERN
BLOTTING MARKET, BY KITS, 2023 & 2032 (IN %)
FIGURE 7: EUROPE WESTERN
BLOTTING MARKET, BY OTHER CONSUMABLES, 2024-2032 (IN $ MILLION)
FIGURE 8: EUROPE WESTERN
BLOTTING MARKET, BY INSTRUMENTS, 2023 & 2032 (IN %)
FIGURE 9: EUROPE WESTERN
BLOTTING MARKET, BY GEL ELECTROPHORESIS INSTRUMENTS, 2024-2032 (IN $ MILLION)
FIGURE 10: EUROPE WESTERN
BLOTTING MARKET, BY BLOTTING SYSTEMS, 2024-2032 (IN $ MILLION)
FIGURE 11: EUROPE WESTERN
BLOTTING MARKET, BY BLOTTING SYSTEMS, 2023 & 2032 (IN %)
FIGURE 12: EUROPE WESTERN
BLOTTING MARKET, BY DRY BLOTTING SYSTEMS, 2024-2032 (IN $ MILLION)
FIGURE 13: EUROPE WESTERN
BLOTTING MARKET, BY SEMI-DRY BLOTTING SYSTEMS, 2024-2032 (IN $ MILLION)
FIGURE 14: EUROPE WESTERN
BLOTTING MARKET, BY WET BLOTTING SYSTEMS, 2024-2032 (IN $ MILLION)
FIGURE 15: EUROPE WESTERN
BLOTTING MARKET, BY IMAGERS, 2023 & 2032 (IN %)
FIGURE 16: EUROPE WESTERN
BLOTTING MARKET, BY CHEMILUMINESCENT IMAGERS, 2024-2032 (IN $ MILLION)
FIGURE 17: EUROPE WESTERN
BLOTTING MARKET, BY FLUORESCENT IMAGERS, 2024-2032 (IN $ MILLION)
FIGURE 18: EUROPE WESTERN
BLOTTING MARKET, BY OTHER IMAGERS, 2024-2032 (IN $ MILLION)
FIGURE 19: EUROPE WESTERN
BLOTTING MARKET, BY APPLICATION, 2023 & 2032 (IN %)
FIGURE 20: EUROPE WESTERN
BLOTTING MARKET, BY BIOMEDICAL & BIOCHEMICAL RESEARCH, 2024-2032 (IN $
MILLION)
FIGURE 21: EUROPE WESTERN
BLOTTING MARKET, BY DISEASE DIAGNOSTICS, 2024-2032 (IN $ MILLION)
FIGURE 22: EUROPE WESTERN
BLOTTING MARKET, BY AGRICULTURE, 2024-2032 (IN $ MILLION)
FIGURE 23: EUROPE WESTERN
BLOTTING MARKET, BY OTHER APPLICATIONS, 2024-2032 (IN $ MILLION)
FIGURE 24: EUROPE WESTERN
BLOTTING MARKET, BY END-USER, 2023 & 2032 (IN %)
FIGURE 25: EUROPE WESTERN
BLOTTING MARKET, BY RESEARCH INSTITUTES, 2024-2032 (IN $ MILLION)
FIGURE 26: EUROPE WESTERN
BLOTTING MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2024-2032 (IN
$ MILLION)
FIGURE 27: EUROPE WESTERN
BLOTTING MARKET, BY DIAGNOSTIC CENTERS, 2024-2032 (IN $ MILLION)
FIGURE 28: EUROPE WESTERN
BLOTTING MARKET, BY OTHER END-USERS, 2024-2032 (IN $ MILLION)
FIGURE 29: EUROPE WESTERN
BLOTTING MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 30: UNITED KINGDOM
WESTERN BLOTTING MARKET 2024-2032 (IN $ MILLION)
FIGURE 31: GERMANY WESTERN
BLOTTING MARKET 2024-2032 (IN $ MILLION)
FIGURE 32: FRANCE WESTERN
BLOTTING MARKET 2024-2032 (IN $ MILLION)
FIGURE 33: SPAIN WESTERN
BLOTTING MARKET 2024-2032 (IN $ MILLION)
FIGURE 34: ITALY WESTERN
BLOTTING MARKET 2024-2032 (IN $ MILLION)